Welgene Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	199.29	224.33	173.5	188.13	158.59	199.77
Short-Term Investments	3	43	53	9	59	21
Trading Asset Securities	-	-	-	-	-	2.72
Cash & Short-Term Investments	202.29	267.33	226.5	197.13	217.59	223.49
Cash Growth	-15.75%	18.03%	14.90%	-9.40%	-2.64%	23.24%
Accounts Receivable	40.21	46.7	45.58	46.98	46.57	82.86
Other Receivables	1.72	1.4	3.61	3.24	0.75	4.28
Receivables	41.93	48.09	49.19	50.23	47.31	87.14
Inventory	46.38	39.08	36.88	53.77	33.98	26.99
Prepaid Expenses	3.77	4.63	5.96	4.45	2.46	2.74
Other Current Assets	7.32	4.69	5.32	0.71	0.86	0.77
Total Current Assets	301.68	363.83	323.84	306.28	302.2	341.13
Property, Plant & Equipment	226.15	234.45	174.88	198.82	78.63	30.67
Long-Term Investments	17.51	17.61	26.12	33.98	42.09	41.36
Other Intangible Assets	16.71	0.65	0.16	0.39	0.73	1.07
Long-Term Deferred Tax Assets	0.67	0.51	0.44	0.56	0.49	0.69
Other Long-Term Assets	32.31	5.15	2.8	8.13	11.57	9.62
Total Assets	595.03	622.19	528.25	548.16	435.71	424.54
Accounts Payable	14.51	25.17	16.91	17.37	18.99	12.53
Accrued Expenses	-	25.43	24.28	21.18	25.02	26.61
Short-Term Debt	14	12	9	11	11.21	12.56
Current Portion of Long-Term Debt	28.7	28.04	11.68	11.05	-	-
Current Portion of Leases	14.64	14.55	13.58	13.33	13.08	11.28
Current Income Taxes Payable	-	-	0.36	-	2.44	-
Current Unearned Revenue	49.46	54.2	56.13	46.18	29.45	46.53
Other Current Liabilities	32.76	5.02	4.66	7.84	4.51	4.71
Total Current Liabilities	154.08	164.4	136.59	127.94	104.71	114.22
Long-Term Debt	134.16	141.19	95.58	105.4	-	-
Long-Term Leases	26.55	30.25	-	13.58	26.9	-
Pension & Post-Retirement Benefits	-	-	-	-	0.12	0.24
Long-Term Deferred Tax Liabilities	0.26	0.26	0.32	0.3	0.03	0.02
Other Long-Term Liabilities	0.08	0.02	0.02	0.68	-	-
Total Liabilities	315.13	336.12	232.5	247.89	131.76	114.47
Common Stock	233.04	233.04	233.04	233.04	233.04	233.04
Additional Paid-In Capital	50.93	50.93	50.86	50.86	50.86	50.86
Retained Earnings	15.01	21.29	20.62	19.51	27.18	28.88
Comprehensive Income & Other	-24.07	-23.97	-16.61	-11.38	-7.32	-2.92
Total Common Equity	274.92	281.3	287.91	292.03	303.76	309.86
Minority Interest	4.98	4.78	7.84	8.24	0.2	0.21
Shareholders' Equity	279.9	286.07	295.75	300.27	303.95	310.06
Total Liabilities & Equity	595.03	622.19	528.25	548.16	435.71	424.54
Total Debt	218.06	226.03	129.83	154.35	51.19	23.84
Net Cash (Debt)	-15.77	41.31	96.66	42.78	166.4	199.64
Net Cash Growth	-	-57.27%	125.94%	-74.29%	-16.65%	31.38%
Net Cash Per Share	-0.68	1.77	4.15	1.84	7.13	8.64
Filing Date Shares Outstanding	23.3	23.3	23.3	23.3	23.3	23.3
Total Common Shares Outstanding	23.3	23.3	23.3	23.3	23.3	23.3
Working Capital	147.61	199.43	187.25	178.34	197.49	226.92
Book Value Per Share	11.80	12.07	12.35	12.53	13.03	13.30
Tangible Book Value	258.2	280.65	287.75	291.64	303.03	308.79
Tangible Book Value Per Share	11.08	12.04	12.35	12.51	13.00	13.25
Land	-	22.76	22.76	22.76	-	-
Buildings	-	97.7	97.7	97.7	-	-
Machinery	-	126.84	93.49	107.46	77.2	55.9